ES296226Y - Capsula de voina dura para la administracion de compuestos farmaceuticamente activos. - Google Patents

Capsula de voina dura para la administracion de compuestos farmaceuticamente activos.

Info

Publication number
ES296226Y
ES296226Y ES1985296226U ES296226U ES296226Y ES 296226 Y ES296226 Y ES 296226Y ES 1985296226 U ES1985296226 U ES 1985296226U ES 296226 U ES296226 U ES 296226U ES 296226 Y ES296226 Y ES 296226Y
Authority
ES
Spain
Prior art keywords
voine
capsule
administration
hard
active compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES1985296226U
Other languages
English (en)
Other versions
ES296226U (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25696968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES296226(Y) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CH5101/84A external-priority patent/CH666809A5/de
Priority claimed from GB8507384A external-priority patent/GB2172570B/en
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of ES296226U publication Critical patent/ES296226U/es
Application granted granted Critical
Publication of ES296226Y publication Critical patent/ES296226Y/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/072—Sealing capsules, e.g. rendering them tamper-proof

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Seasonings (AREA)
  • Closing Of Containers (AREA)
ES1985296226U 1984-10-25 1985-10-24 Capsula de voina dura para la administracion de compuestos farmaceuticamente activos. Expired ES296226Y (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH5101/84A CH666809A5 (de) 1984-10-25 1984-10-25 Steckkapseln zur aufnahme wirkstoff enthaltender substanzen.
GB8507384A GB2172570B (en) 1985-03-21 1985-03-21 Hard gelatin capsules.

Publications (2)

Publication Number Publication Date
ES296226U ES296226U (es) 1987-08-01
ES296226Y true ES296226Y (es) 1988-02-16

Family

ID=25696968

Family Applications (1)

Application Number Title Priority Date Filing Date
ES1985296226U Expired ES296226Y (es) 1984-10-25 1985-10-24 Capsula de voina dura para la administracion de compuestos farmaceuticamente activos.

Country Status (14)

Country Link
EP (1) EP0180543B1 (es)
JP (1) JP2552647B2 (es)
KR (1) KR930007655B1 (es)
AU (1) AU596787B2 (es)
BG (1) BG60376B2 (es)
BR (1) BR8505406A (es)
CA (1) CA1252441A (es)
DE (1) DE3582650D1 (es)
EG (1) EG17210A (es)
ES (1) ES296226Y (es)
IE (1) IE58468B1 (es)
MX (1) MX165120B (es)
PH (1) PH25373A (es)
YU (1) YU45286B (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4756902A (en) * 1986-06-02 1988-07-12 Warner-Lambert Company Capsule sealing process and product
KR890003520Y1 (ko) * 1986-12-20 1989-05-27 주식회사 서흥캅셀 의약용 캅셀
FR2617864B1 (fr) * 1987-07-10 1990-08-17 Instr Medecine Veterinaire Receptacle de confinement d'un liquide biologique
GR1000200B (el) * 1988-12-08 1992-03-20 Su Heung Capsule Co Ltd Kaψουλα φαρμακων.
JPH0774149B2 (ja) * 1991-12-27 1995-08-09 藤本製薬株式会社 硬ゼラチンカプセル
KR0124764Y1 (ko) * 1995-09-23 1998-09-15 양주환 의약 및 식품용 하드 공 캅셀
JP4294862B2 (ja) 1997-12-26 2009-07-15 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー ゼラチン組成物
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1649886B1 (en) * 1999-07-23 2008-04-02 MannKind Corporation Unit dose capsules for a dry powder inhaler
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US7305986B1 (en) 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
EP1072245A1 (en) * 1999-07-30 2001-01-31 Warner-Lambert Company Method and apparatus for sealing capsules and capsules suitable for use in said method and apparatus
US6949154B2 (en) 2001-07-28 2005-09-27 Boehringer Ingelheim Pharma Kg Method and apparatus for sealing medicinal capsules
ES2294123T5 (es) 2001-08-16 2012-06-29 Capsugel Belgium Nv Envase soluble en agua
EP1894591B1 (en) 2002-03-20 2013-06-26 MannKind Corporation Cartridge for an inhalation apparatus
EP1459725B1 (en) 2003-03-21 2007-10-17 Warner-Lambert Company LLC Apparatus for and method of sealing capsules
EP1702555B1 (en) 2004-01-07 2016-12-07 Olympus Corporation Capsule type medical device, medical capsule enclosure and production method therefor
JP4578874B2 (ja) * 2004-07-15 2010-11-10 オリンパス株式会社 カプセル型医療装置
DK1786784T3 (da) 2004-08-20 2011-02-14 Mannkind Corp Katalyse af diketopiperazinsyntese
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
DE102005001332A1 (de) * 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
US8377471B2 (en) * 2005-08-09 2013-02-19 Capsugel Belgium Nv Container
HUE028623T2 (en) 2005-09-14 2016-12-28 Mannkind Corp Active substance formulation method based on increasing the affinity of the active ingredient for binding to the surface of crystalline microparticles
IN2015DN00888A (es) 2006-02-22 2015-07-10 Mannkind Corp
NL1033047C2 (nl) * 2006-12-13 2008-06-16 Pharmachemie Bv Capsule, gevuld met een medicijn, in het bijzonder een inhaleerbaar medicijn.
EP2104482A1 (en) * 2007-01-16 2009-09-30 Dow Global Technologies Inc. Oral drug capsule component incorporating a communication device
WO2009007377A1 (de) * 2007-07-10 2009-01-15 Boehringer Ingelheim International Gmbh Dichtes verschliessen von gefüllten arzneimittelkapseln
EP2020220A1 (de) * 2007-08-03 2009-02-04 Boehringer Ingelheim Pharma GmbH & Co. KG Dichtes Verschließen von gefüllten Arzneimittelkapseln
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2570400T3 (es) 2008-06-13 2016-05-18 Mannkind Corp Un inhalador de polvo seco y un sistema para el suministro de fármacos
JP5479465B2 (ja) 2008-06-20 2014-04-23 マンカインド コーポレイション 吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2405963B1 (en) 2009-03-11 2013-11-06 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
KR101875969B1 (ko) 2009-06-12 2018-07-06 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
US8790692B2 (en) * 2009-09-09 2014-07-29 Patheon Pharmaceuticals Inc. Break resistant gel capsule
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
EA201290317A1 (ru) 2009-11-13 2012-10-30 Кэпсьюджел Белджиум Нв Способ контроля герметичных капсул с использованием процесса определения качества герметичности, а также соответствующее оборудование для контроля на производственной линии
MX359281B (es) 2010-06-21 2018-09-21 Mannkind Corp Sistema y metodos para suministrar un farmaco en polvo seco.
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
CN103945859A (zh) 2011-10-24 2014-07-23 曼金德公司 用于治疗疼痛的方法和组合物
WO2014012069A2 (en) 2012-07-12 2014-01-16 Mannkind Corporation Dry powder drug delivery systems and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9775813B2 (en) 2013-05-10 2017-10-03 Capsugel Belgium Nv Separable capsule
KR102321339B1 (ko) 2013-07-18 2021-11-02 맨카인드 코포레이션 열-안정성 건조 분말 약제학적 조성물 및 방법
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
KR20160065973A (ko) * 2013-10-07 2016-06-09 모노졸, 엘엘씨 수용성 지연 방출 캡슐, 관련된 방법, 및 관련된 제품
JP6691478B2 (ja) * 2013-10-07 2020-04-28 モノソル リミテッド ライアビリティ カンパニー 水溶性遅延放出カプセル、関連する方法および関連する物品
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN106619128B (zh) * 2015-11-04 2019-12-06 曹荣华 胶囊的封存组合物及其封存方法
ES2745585T3 (es) 2016-03-15 2020-03-02 Capsugel Belgium Nv Aparato y métodos para el sellado de cápsulas duras asépticas
AU2018346826B2 (en) * 2017-10-02 2021-09-16 Novartis Ag Method for preparing a pharmaceutical product
WO2022016397A1 (zh) * 2020-07-22 2022-01-27 绍兴康可胶囊有限公司 羟丙甲纤维素空心胶囊
CN113164404B (zh) * 2020-07-22 2022-09-02 绍兴康可胶囊有限公司 肠溶羟丙甲纤维素空心胶囊
CN112353776B (zh) * 2020-11-18 2022-08-16 湖北灵铠智能装备有限公司 一种改良型胶囊及封装方法
JP2023552859A (ja) * 2020-12-14 2023-12-19 キャプシュゲル・ベルジウム・エヌ・ヴィ カプセルを密封するための密封流体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3508678A (en) * 1968-04-29 1970-04-28 Parke Davis & Co Locking capsule
US3823843A (en) * 1972-10-26 1974-07-16 Lilly Co Eli Locking capsule
DE2333753A1 (de) * 1973-07-03 1975-01-30 Basf Ag Freitragende kapsel
US4040536A (en) * 1975-05-05 1977-08-09 R. P. Scherer Corporation Locking hard gelatin capsule
US4026986A (en) * 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
DE2729007A1 (de) * 1977-06-28 1979-01-18 Rainer Dr Med Liedtke Arzneikapsel mit zwei kammern
US4281763A (en) * 1979-10-31 1981-08-04 Pace Joseph A Two-piece hardshell, soluble and digestible liquid containing gelatin capsule
US4522666A (en) * 1982-11-09 1985-06-11 Warner-Lambert Company Apparatus and method for sealing capsules by application of vacuum and steam thereto
EP0116744A1 (en) * 1982-12-20 1984-08-29 Warner-Lambert Company Apparatus for and method of sealing capsules
US4656066A (en) * 1982-12-20 1987-04-07 Warner-Lambert Company Apparatus and method for sealing capsules
US4539060A (en) * 1983-02-18 1985-09-03 Warner-Lambert Company Apparatus and method of sealing capsules
JPS59174158A (ja) * 1983-03-24 1984-10-02 エーザイ株式会社 ゼラチン硬カプセルのボデ−とキヤツプとのシ−ル方法及びその装置
JPS6176416A (ja) * 1984-09-20 1986-04-18 Fujimoto Seiyaku Kk 活性型ビタミンｄ↓３誘導体のカプセル剤用組成物

Also Published As

Publication number Publication date
KR930007655B1 (ko) 1993-08-18
BG60376B2 (bg) 1995-01-03
BR8505406A (pt) 1986-08-05
YU168585A (en) 1988-06-30
KR860003007A (ko) 1986-05-19
YU45286B (en) 1992-05-28
CA1252441A (en) 1989-04-11
AU4903085A (en) 1986-05-01
EP0180543A3 (en) 1988-03-02
EP0180543B1 (en) 1991-04-24
AU596787B2 (en) 1990-05-17
DE3582650D1 (de) 1991-05-29
IE852514L (en) 1986-04-25
MX165120B (es) 1992-10-28
JP2552647B2 (ja) 1996-11-13
IE58468B1 (en) 1993-09-22
PH25373A (en) 1991-06-03
EG17210A (en) 1990-12-30
JPS61168357A (ja) 1986-07-30
EP0180543A2 (en) 1986-05-07
ES296226U (es) 1987-08-01

Similar Documents

Publication Publication Date Title
ES296226Y (es) Capsula de voina dura para la administracion de compuestos farmaceuticamente activos.
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO883974D0 (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO851949L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO883485L (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO885598D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive ammoniumforbindelser.
NO883500L (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
NO890155D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO873514D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO864101L (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO881768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO165295C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.

Legal Events

Date Code Title Description
FD1K Utility model lapsed

Effective date: 20071215